Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
deals
life sciences
national blog main
boston
boston blog main
boston top stories
crispr
editas medicine
national top stories
roche
abbvie
acquisitions
advanced therapies
alexion pharmaceuticals
allergan
alnylam pharmaceuticals
alzheimer's disease
atmp
avexis
bioprocess insider
bms
boehringer ingelheim
brammer bio
bristol-myers squibb
cancer
car-t
car-t chimeric antigen receptor
catalent
cell & gene
cell gene therapy
cell therapeutics
cell therapies
crispr therapeutics
cynthia collins
dicerna pharamceuticals
drugs
europe blog main
falcon therapeutics
What
gene
3
×
medicines
research
abbvie
access
advanced
alliance
biotech
capacity
car
caught
causing
cell
consolidation
crispr
dicerna
disease
drug
editas
editing
exits
experimental
eye
falcon
focus
genetic
hepatitis
intended
milestones
pact
partnership
patient
pay
pharma
pharmaceuticals
powered
proactive
producing
protein
pruning
Language
unset
3
×
Current search:
unset
×
" clinical trials "
×
gene
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug